COMMUNIQUÉS West-GlobeNewswire

-
The BRAVE Trauma Therapist Collective Launches Second Annual Reach 100 Drive to Strengthen Trauma Therapist Community
07/04/2025 -
One Million Kids, One Mission: Sevaro & Yale School of Medicine Stroke Neurologists Unite to Teach Stroke Awareness
07/04/2025 -
Conversations Today to Empower Tomorrow: VITAS® Healthcare Elevates National Healthcare Decisions Day
07/04/2025 -
XTL Names Mr. Noam Band as its New Chief Executive Officer
07/04/2025 -
European Commission approves subcutaneous RYBREVANT®▼ (amivantamab) for the treatment of patients with advanced EGFR-mutated non-small cell lung cancer
07/04/2025 -
Nelipak® Healthcare Packaging Expands Commitment to Serve Customers in Asia-Pacific Region with its Sterile Barrier Medical Packaging Products
07/04/2025 -
Surplus Solutions, an NMS Capital Portfolio Company, Expands Capabilities in Refurbished Laboratory Equipment and Technical Services; Announces Partnership with Certified Genetool
07/04/2025 -
Rectify Pharma Announces Publication of BSEP Transporter Biophysical Characterization in Communications Biology
07/04/2025 -
Sharecare Names Industry Veteran Elizabeth Delahoussaye as Chief Privacy Officer of Health Data Solutions
07/04/2025 -
ImmuCell Hires Chief Financial Officer
07/04/2025 -
NEXGEL to Present at the Planet MicroCap Showcase in Las Vegas, NV April 22nd-24th
07/04/2025 -
Better Choice Company Issues Stock Dividend of 0.35 per Share for Each Share Held for Stockholders of Record as of April 17, 2025
07/04/2025 -
Cannabix Technologies to Attend Tennessee Safety and Health Conference to Exhibit Alcohol and Marijuana Breath Testing Technologies
07/04/2025 -
Senti Bio Joins Webull Corporate Connect Service Platform
07/04/2025 -
Noom appoints Dr. Jeffrey Egler as Chief Medical Officer to Lead Innovation in Healthy Aging and Longevity
07/04/2025 -
Allogene Granted Three U.S. FDA Fast Track Designations (FTD) for ALLO-329, a Next-Generation Dual-Targeted CD19/CD70 Allogeneic CAR T, for the Treatment of Lupus, Myositis and Scleroderma
07/04/2025 -
Conduit Pharmaceuticals Expands Partnership with Sarborg Limited to Leverage Machine Learning Data Analysis for Pipeline Optimization
07/04/2025 -
NKGen Biotech Presents Data from Phase 1/2a Clinical Trial of Troculeucel in Moderate Alzheimer’s Disease at the International Conference on Alzheimer’s and Parkinson’s Diseases (AD/PD™ 2025)
07/04/2025 -
Stryker to announce financial results for its first quarter of fiscal year 2025
07/04/2025
Pages